Michael Neumaier

9.7k total citations · 1 hit paper
220 papers, 6.5k citations indexed

About

Michael Neumaier is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Michael Neumaier has authored 220 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Molecular Biology, 45 papers in Radiology, Nuclear Medicine and Imaging and 38 papers in Oncology. Recurrent topics in Michael Neumaier's work include Monoclonal and Polyclonal Antibodies Research (27 papers), Cancer Genomics and Diagnostics (21 papers) and Radiopharmaceutical Chemistry and Applications (20 papers). Michael Neumaier is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (27 papers), Cancer Genomics and Diagnostics (21 papers) and Radiopharmaceutical Chemistry and Applications (20 papers). Michael Neumaier collaborates with scholars based in Germany, United States and Italy. Michael Neumaier's co-authors include Christoph Wagener, Peter Findeisen, Markus Gerhard, Parviz Ahmad‐Nejad, Holger Kalthoff, John E. Shively, Jost B. Jonas, R. Jung, Hans Schreiber and Andreas Braun and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Michael Neumaier

212 papers receiving 6.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy

2003 603 citations Michael Neumaier et al. profile →

Peers

Countries citing papers authored by Michael Neumaier

Since Specialization

Citations

This map shows the geographic impact of Michael Neumaier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Neumaier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Neumaier more than expected).

Fields of papers citing papers by Michael Neumaier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Neumaier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Neumaier. The network helps show where Michael Neumaier may publish in the future.

Co-authorship network of co-authors of Michael Neumaier

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Neumaier. A scholar is included among the top collaborators of Michael Neumaier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Neumaier. Michael Neumaier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Machine learning-based forecasting of daily acute ischemic stroke admissions using weather data 2025 ·npj Digital Medicine ·(unknown), Kim Eun Hee, David Rügamer, Andreas Bender, Stefan Muthers, (unknown), Angelika Alonso, Kristina Szabo, (unknown), Holger Wenz, Thomas Ganslandt, Michael Platten, Christoph Groden, Michael Neumaier, Fabian Siegel, Máté E. Maros	1
2	Urgent call to the European Commission to simplify and contextualize IVDR Article 5.5 for tailored and precision diagnostics 2025 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Christa M. Cobbaert, Christian Schweiger, Christoph Buchta, Thomas Streichert, Florent Vanstapel, François Mullier, (unknown), Ettore Capoluongo, Patrick M. Bossuyt, Harjit Pal Bhattoa, Tom Melvin, Michael Neumaier	2
3	ISO 15189 is a sufficient instrument to guarantee high-quality manufacture of laboratory developed tests for in-house-use conform requirements of the European In-Vitro-Diagnostics Regulation 2023 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Florent Vanstapel, Matthias Orth, Thomas Streichert, Ettore Capoluongo, Wytze P. Oosterhuis, Hikmet Can Çubukçu, Francisco A. Bernabéu-Andréu, Marc Thelen, Leo Jacobs, Solveig Linko, Harjit Pal Bhattoa, Patrick M. Bossuyt, Pika Meško Brguljan, Guilaine Boursier, Christa M. Cobbaert, Michael Neumaier	23
4	Integrative Diagnostics: The Time Is Now—A Report From the International Society for Strategic Studies in Radiology 2022 ·Journal of the American College of Radiology ·(unknown), R. Nick Bryan, Marilyn M. Bui, Gabriël P. Krestin, Geraldine McGinty, Carolyn C. Meltzer, Michael Neumaier	3
5	Plasma-based S100B testing for management of traumatic brain injury in emergency setting 2021 ·Practical Laboratory Medicine ·Verena Haselmann, (unknown), (unknown), Volker Ast, Matthias F. Froelich, (unknown), Maximilian Kittel, (unknown), (unknown), Michael Neumaier, Eva Neumaier‐Probst	18
6	Implementation of the new EU IVD regulation – urgent initiatives are needed to avert impending crisis 2021 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Christa M. Cobbaert, Ettore Capoluongo, Florent Vanstapel, Patrick M. Bossuyt, Harjit Pal Bhattoa, Peter H. Nissen, Matthias Orth, Thomas Streichert, Ian Young, Elizabeth Macintyre, Alan G. Fraser, Michael Neumaier	17
7	The macrophage-TCRαβ is a cholesterol-responsive combinatorial immune receptor and implicated in atherosclerosis 2014 ·Biochemical and Biophysical Research Communications ·(unknown), (unknown), Alexander Emmert, (unknown), (unknown), R. Laird, (unknown), Katrin Schäfer, Michael Neumaier, A. Beham, Wolfgang E. Kaminski	27
8	Diagnostic and Prognostic Value of Osteopontin in Patients with Acute Congestive Heart Failure 2013 ·European Journal of Heart Failure ·Michael Behnes, Martina Brueckmann, Siegfried Lang, (unknown), Christel Weiß, Michael Neumaier, Parviz Ahmad‐Nejad, Martin Borggrefe, Ursula Hoffmann	25
9	Loss of Expression of the Tumor Suppressor CEACAM1 Links Different Hereditary Colorectal Carcinoma Subtypes to the Genesis of Sporadic Colorectal Carcinoma 2012 ·Onkologie ·(unknown), Stefanie Nittka, Michael Neumaier	3
10	The Presence of Functionally Relevant Toll-Like Receptor Polymorphisms Does Not Significantly Correlate with Development or Outcome of Sepsis 2011 ·Genetic Testing and Molecular Biomarkers ·Parviz Ahmad‐Nejad, Christof Denz, (unknown), Jennifer L. Wacker, Peter Bugert, Christel Weiß, Michael Quintel, Michael Neumaier	14
11	Influence of high dose tumescent local anaesthesia with prilocaine on systemic interleukin (IL)‐6, IL‐8 and tumour necrosis factor‐α 2010 ·Journal of the European Academy of Dermatology and Venereology ·(unknown), Jörg Faulhaber, (unknown), (unknown), Jörg Oliver Thumfart, (unknown), Michael Neumaier, (unknown)	5
12	Laboratory Management of Samples in Biobanks: European Consensus Expert Group Report 2010 ·Biopreservation and Biobanking ·Martin Yuille, Thomas Illig, Kristian Hveem, Gerd Schmitz, (unknown), Michael Neumaier, Gunnel Tybring, Erich Wichmann, Bill Ollier	22
13	Spiking of serum specimens with exogenous reporter peptides for mass spectrometry based protease profiling as diagnostic tool 2008 ·Rapid Communications in Mass Spectrometry ·Peter Findeisen, Teresa Peccerella, Stefan Post, Frederik Wenz, Michael Neumaier	15
14	The 7th EFCC Continuous Postgraduate Course in Clinical Chemistry: New trends in diagnosis, monitoring and management using molecular diagnosis methods 2007 ·Ana Stavljenić-Rukavina, Maurizio Ferrari, Laura Cremonesi, Stefania Stenirri, Silvia Galbiati, György Kosztolányi, Krešimir Pavelić, (unknown), Sandra Kraljević Pavelić, Mirela Sedić, Elizabeta Topić, Ron H. N. van Schaik, Janja Marc, Dorota Tomalik‐Scharte, Ana-Maria Šimundić, (unknown), Michael Neumaier	1
15	Characterization and investigation of single nucleotide polymorphisms and a novel TLR2 mutation in the human TLR2 gene 2007 ·Human Molecular Genetics ·(unknown), Michael Neumaier, Hermann Wagner, Carsten J. Kirschning, Parviz Ahmad‐Nejad	44
16	Systematic identification of substrates for profiling of secreted proteases from Aspergillus species 2007 ·Journal of Microbiological Methods ·(unknown), Claudio Kupfahl, Dieter Buchheidt, Michael Neumaier, Peter Findeisen	10
17	CEACAM1 modulates epidermal growth factor receptor–mediated cell proliferation 2004 ·Journal of Clinical Investigation ·George A. Abou-Rjaily, Sang Jun Lee, Denisa May, Qusai Y. Al–Share, Anthony M. DeAngelis, Randall J. Ruch, Michael Neumaier, Holger Kalthoff, Sue-Hwa Lin, Sonia M. Najjar	21
18	CEACAM1 modulates epidermal growth factor receptor–mediated cell proliferation 2004 ·Journal of Clinical Investigation ·George A. Abou-Rjaily, Sang Jun Lee, Denisa May, Qusai Y. Al–Share, Anthony M. DeAngelis, Randall J. Ruch, Michael Neumaier, Holger Kalthoff, Sue-Hwa Lin, Sonia M. Najjar	55
19	Multiparametrische Gendiagnostik in der Medizin: Erarbeitung gemeinsamer Standards. Multiparametric Gene Diagnostics in Medicine: Development of Consensus Standards 2003 ·LaboratoriumsMedizin ·(unknown), Paul Cullen, (unknown), (unknown), Cornelius Knabbe, Thomas Langmann, Michael Neumaier	1
20	Fundamentals of quality assessment of molecular amplification methods in clinical diagnostics 1998 ·Clinical Chemistry ·Michael Neumaier, Andreas Braun, Christoph Wagener, (unknown)	72

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact